FIELD: medicine.
SUBSTANCE: method for determining a perivascular water index (PVWi) of a blood vessel includes: (i) using data collected from a computed tomography scan along the length of the vessel to determine the total volume of water voxels within the attenuation window around the attenuation for water within the perivascular space at a predetermined distance from the outer wall of the vessel and (ii) correcting the total volume of water voxels by the volume of the vessel by dividing the total volume of water voxels determined at stage (i) by the total perivascular volume. The perivascular water index (PVWi) is used as a functional biological marker of vascular inflammation. A method for predicting the risk of mortality or risk in a patient suffering from a cardiac event includes: (a) using data collected from a computed tomography (CT) scan along the length of a blood vessel to determine: (i) a calcium index (Calcium-i) and/or (ii) a fibrous plaque index (FPi) and at least one of (iii) a fat attenuation index in perivascular adipose tissue (FAIPVAT); (iv) a perivascular water index (PVWi) and/or (v) a fat attenuation index in epicardial adipose tissue (FAIEpAT); and (b) comparing each of values determined in (a) with a predetermined separation value or applying the absolute value of each variable to obtain an output value that indicates the risk that the patient suffers from a cardiac event.
EFFECT: use of this group of inventions will allow non-invasive detection of vascular inflammation and will provide the possibility to identify patients who are at risk of suffering from serious cardiac events.
26 cl, 9 dwg, 4 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING DENSITY OF PERIVASCULAR ADIPOSE TISSUE ACCORDING TO MULTISPIRAL COMPUTED TOMOGRAPHY | 2023 |
|
RU2820216C1 |
METHOD FOR OSTEOPENIC SYNDROME DEVELOPMENT PROBABILITY DETERMINATION IN PATIENTS WITH MULTIFOCAL ATHEROSCLEROSIS | 2016 |
|
RU2624816C1 |
METHOD FOR VISCERAL OBESITY DETERMINATION BASED ON MAGNETIC RESONANCE TOMOGRAPHY OF HEART | 2018 |
|
RU2721542C2 |
METHOD OF PREDICTING PROBABILITY OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE WHO HAVE UNDERGONE PLANNED CORONARY MYOCARDIAL REVASCULARIZATION | 2023 |
|
RU2814112C1 |
METHOD FOR PREDICTION OF RISK OF LATE POST-ABLATING RELAPSE OF ATRIAL FIBRILLATION IN PATIENTS WITH ATRIAL FIBRILLATION WITHOUT STRUCTURAL AND FUNCTIONAL CHANGES IN MYOCARDIUM BASED ON RADIOMIC ANALYSIS OF EPICARDIAL ADIPOSE TISSUE | 2022 |
|
RU2789384C1 |
METHOD OF PREDICTING RISK OF DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES WITH PRIOR CORONARY ARTERY STENTING | 2015 |
|
RU2582291C1 |
METHOD FOR DETERMINING SEVERE DEGREE OF CALCIFIED DIFFUSE CORONARY ARTERY LESION | 2020 |
|
RU2750717C1 |
METHOD FOR REVASCULARISATION OF MULTIPLE CORONARY BED LESION ACCOMPANYING ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | 2013 |
|
RU2544096C1 |
METHOD OF NONINVASIVE DIAGNOSTICS OF ADIPOCYTE HYPERTROPHY OF EPICARDIAL ADIPOSE TISSUE OF PATIENTS WITH ISCHEMIC HEART DISEASE AND CORONARY ATHEROSCLEROSIS | 2020 |
|
RU2743837C1 |
DIAGNOSTIC TECHNIQUE OF INFLAMMATION IN EPICARDIAL ADIPOSE TISSUE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CORONARY ATHEROSCLEROSIS | 2020 |
|
RU2728097C1 |
Authors
Dates
2021-10-29—Published
2017-10-31—Filed